Final Prospectus Filed for Adirondack Bancorp Acquisition Ahead of Shareholder Vote
summarizeSummary
Arrow Financial Corp. filed the definitive prospectus for its $89.1 million acquisition of Adirondack Bancorp, Inc., detailing the cash and stock merger ahead of the June 9, 2026 shareholder vote. The deal is expected to be accretive to EPS but dilutive to tangible book value.
check_boxKey Events
-
Acquisition Details Finalized
Arrow Financial is acquiring Adirondack Bancorp for approximately $89.1 million, with Adirondack shareholders to receive 1.8610 shares of Arrow common stock and $18.72 in cash for each share. This finalizes the terms of the offering initiated on February 26, 2026.
-
Shareholder Vote Scheduled
Adirondack shareholders will vote on the merger agreement on June 9, 2026. Approval by a majority of votes is a condition for the merger's completion.
-
Financial Impact for Arrow
The merger is anticipated to be accretive to Arrow's estimated 2026 and 2027 EPS, but dilutive to its tangible book value per share at closing. Arrow's capital ratios are also expected to be lower post-merger.
-
Potential Dilution
Arrow expects to issue approximately 2.0 million shares of its common stock in the merger, representing about 9.06% potential dilution to existing Arrow shareholders.
auto_awesomeAnalysis
This filing is the definitive proxy statement/prospectus for the previously announced acquisition of Adirondack Bancorp by Arrow Financial. While the core terms of the $89.1 million cash and stock merger were disclosed in February 2026, this document is a critical procedural step, providing final details for the upcoming shareholder vote on June 9, 2026. The acquisition is expected to be accretive to Arrow's EPS but will result in tangible book value dilution and a potential 9.06% increase in Arrow's outstanding shares. The integration of key Adirondack executives into Arrow's leadership team is also outlined.
At the time of this filing, AROW was trading at $36.39 on NASDAQ in the Finance sector, with a market capitalization of approximately $601.5M. The 52-week trading range was $24.57 to $38.09. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.